STAT-Site M BHB Test Strips, used with STAT-SITE M Beta-HB Meter as an in vitro diagnostic for bl...
FDA Device Recall #Z-0490-2024 — Class II — October 2, 2023
Recall Summary
| Recall Number | Z-0490-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 2, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Stanbio Laboratory, LP |
| Location | Boerne, TX |
| Product Type | Devices |
| Quantity | 2,351 |
Product Description
STAT-Site M BHB Test Strips, used with STAT-SITE M Beta-HB Meter as an in vitro diagnostic for blood ketone values.
Reason for Recall
Deterioration in the stability of the Test Strips results in diminished low-range detection capability and inability to meet linearity performance claims. The root cause of the stability deterioration in is identified as the change in material that caused a pH shift in the coating solution resulting in precipitation during coating runs. The device defect can cause false negative results that may lead to a delay in treatment of patients with associated conditions such as diabetic ketoacidosis.
Distribution Pattern
Worldwide - US Nationwide distribution including in the states of AZ, RI, MO, UT, AK, LA, TX, OH, GA, MN, NY, CA, NJ, IL, WA, KS, MI, NC, PA, MA, CO, KY, NM, FL, MD, VA, IN, AL, SD, MS, WV, WI, ID, MT, WY and the countries of Canada and Singapore.
Lot / Code Information
UDI-DI: 00657498000090, Lot/Expiration: 203044/2024-01-31, 209644/2024-06-30
Other Recalls from Stanbio Laboratory, LP
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0905-2022 | Class II | Separation Technology Creamatocrit Plus, Catalo... | Mar 16, 2022 |
| Z-2200-2021 | Class III | Beta-Hydroxybutyrate Reagent A - Enzyme (unlabe... | Jul 12, 2021 |
| Z-2201-2021 | Class III | Synchron CX/DX/LX Beta-Hydroxybutyrate . in vi... | Jul 12, 2021 |
| Z-2202-2021 | Class III | Cardinal Health Beta-Hydroxybutyrate . in vitr... | Jul 12, 2021 |
| Z-2199-2021 | Class III | Beta-Hydroxybutyrate LiquiColor. in vitro diag... | Jul 12, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.